NOVO HOLDINGS A/S: 13F holdings
CIK 13883252026Q2
| Positions | 25 |
|---|
| Reported value | $1.7bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 25 (+3 vs prior quarter) |
|---|
| Reported value | $1.7bn (+39.5%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| EWTX EDGEWISE THERAPEUTICS INC | 5,350,000 | $217.4m | 12.6% |
| ASML HOLDING N V | 94,946 | $188.9m | 11.0% |
| HEMAB THERAPEUTICS HLDGS INC | 4,180,550 | $153.6m | 8.9% |
| BN BROOKFIELD CORP | 3,496,245 | $149.5m | 8.7% |
| MAPLIGHT THERAPEUTICS INC | 3,686,622 | $132.1m | 7.7% |
| MIRM MIRUM PHARMACEUTICALS INC | 1,125,000 | $131.7m | 7.6% |
| AVALYN PHARMACEUTICALS INC | 3,883,289 | $127.8m | 7.4% |
| CRM SALESFORCE INC | 393,187 | $61.6m | 3.6% |
| AVBP ARRIVENT BIOPHARMA INC | 1,500,000 | $52.1m | 3.0% |
| ELVN ENLIVEN THERAPEUTICS INC | 1,000,000 | $50.8m | 2.9% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1388325")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples